Options traders have shifted decisively toward calls on MRSH. The put-call ratio has dropped to 0.51 — nearly 1.6 standard deviations below its 20-day average of 0.62. That's close to a 52-week low of 0.49. It is the clearest signal in the current data.
The backdrop is a stock that has moved. MRSH is up 4.3% over the past week and 4.1% over the past month. The options market is leaning into that momentum.
The analyst picture is more nuanced. UBS analyst Brian Meredith cut his price target from $230 to $203 on June 9 — a 12% reduction — while keeping a Buy rating. Piper Sandler trimmed from $190 to $182 in late May. The consensus target sits at $199.86 against a closing price of $168.15. That implies roughly 19% upside at the mean.
The cuts follow a pattern of post-tariff target resets across financial services. Crucially, no firm has downgraded the stock. Citigroup actually upgraded MRSH to Buy in early May with a $200 target. The consensus remains "Hold" with a constructive skew from bulge-bracket names.
Short interest has climbed 10.7% over the past week to 1.49% of free float. The one-month increase is 22%. Shorts are growing. But context matters: 1.49% of float is a low absolute level. The borrow market is entirely relaxed — availability sits at 9,999%, meaning there are hundreds of shares available for every share already borrowed. Cost to borrow is 0.30%, well below historical norms. There is no squeeze pressure here.
The short build looks more like a tactical hedge against the recent price run than a conviction short thesis. ORTEX short score stands at 30.3 — a relatively low reading.
CEO John Doyle sold 16,656 shares on June 2 at $161.71, realising $2.69 million. That follows a $3.05 million sale in early March. The pattern is consistent — periodic monetisation rather than a directional signal — but it is worth noting that the CEO has been a seller as the stock recovered.
Next earnings are scheduled for July 16. Recent prints have been muted movers: Q1 saw a +0.4% one-day reaction, and the five-day follow-through was negative. Options positioning bullishness may partly reflect positioning ahead of that event.
See the live data behind this article on ORTEX.
Open MRSH on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
